Related Experiment Video
Updated: Sep 7, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
The Rel/NF-kappa B family: friend and foe
1Dept of Biochemistry, Division of Gene Regulation and Expression, MSI/WTB Complex, Dow Street, University of Dundee, Dundee, UK DD1 5EH. n.d.perkins@dundee.ac.uk
Abstract:
The members of the Rel/NF-kappa B family of transcription factors form one of the first lines of defense against infectious diseases and cellular stress. These proteins initiate a highly coordinated response in multiple cell types that effectively counteracts the threat to the health of the organism. Conversely, disruption of the regulatory mechanisms that control the specificity and extent of this response, which results in aberrant activation of NF-kappa B, can be one of the primary causes of a wide range of human diseases. Thus, targeting NF-kappa B might lead to the development of new pharmaceutical reagents that could provide novel treatments for many inflammatory diseases and cancer.
Insights
The Rel/NF-kappa B (NF-κB) pathway is crucial for immune defense against pathogens and stress. Aberrant NF-κB activation contributes to diseases, suggesting therapeutic targeting for inflammatory conditions and cancer.
Area of Science:
- Molecular Biology
- Immunology
- Cellular Biology
Background:
- The Rel/NF-kappa B (NF-κB) family of transcription factors plays a vital role in the innate immune response.
- NF-κB proteins orchestrate cellular defense mechanisms against infectious agents and physiological stress.
Purpose of the Study:
- To highlight the critical role of NF-κB in host defense.
- To underscore the pathological consequences of dysregulated NF-κB signaling.
- To propose NF-κB as a therapeutic target for various human diseases.
Main Methods:
- This study is a review and conceptual analysis of the NF-κB signaling pathway.
- It synthesizes existing knowledge on NF-κB function and dysregulation.
Main Results:
- NF-κB acts as a rapid response system against threats.
- Disruptions in NF-κB regulation lead to uncontrolled activation.
- Aberrant NF-κB signaling is implicated in numerous human pathologies.
Conclusions:
- Targeting the NF-κB pathway holds potential for developing novel therapeutics.
- Pharmaceutical intervention in NF-κB signaling could offer new treatments for inflammatory diseases and cancer.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

